More exciting data coming along for pan-KRAS inhibitors BI-2493 and BI-2865, displaying potent anti-tumor activity in tumors with #KRAS wild-type allele amplification. https://lnkd.in/e6rB_Suc Great job by Boehringer Ingelheim
